PWPS
LEGN icon

Pinnacle Wealth Planning Services’s Legend Biotech LEGN Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.74K Sell
95
-315
-77% -$8.5K ﹤0.01% 2411
2026
Q1 		$7.42K Buy
+410
New +$7.82K ﹤0.01% 2128

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Pinnacle Wealth Planning Services's LEGN Position: Q2 2026 in Review

Pinnacle Wealth Planning Services reduced its Legend Biotech (LEGN) stake by 77% in Q2 2026, selling an estimated $8.5K and leaving 95 shares worth $2.74K. The position accounts for ﹤0.01% of the portfolio, ranked #2411.

Pinnacle Wealth Planning Services first reported a position in LEGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $7.42K in Q1 2026. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Pinnacle Wealth Planning Services held 95 shares of Legend Biotech worth $2.74K as of Q2 2026.
  • Pinnacle Wealth Planning Services sold 315 Legend Biotech shares in Q2 2026, an estimated $8.5K.
  • Legend Biotech made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #2411 holding.
  • Pinnacle Wealth Planning Services first reported a position in Legend Biotech in Q1 2026 and has held it in 2 quarters since.
  • Pinnacle Wealth Planning Services's Legend Biotech position peaked at $7.42K in Q1 2026.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.